On Tuesday, NeuroOne Medical Technologies Corp (NASDAQ: NMTC) opened higher 6.47% from the last session, before settling in for the closing price of $1.0. Price fluctuations for NMTC have ranged from $0.40 to $1.39 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 23.14%. Company’s average yearly earnings per share was noted 75.54% at the time writing. With a float of $44.07 million, this company’s outstanding shares have now reached $49.82 million.
The extent of productivity of a business whose workforce counts for 17 workers is very important to gauge.
NeuroOne Medical Technologies Corp (NMTC) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of NeuroOne Medical Technologies Corp is 11.87%, while institutional ownership is 42.03%. The most recent insider transaction that took place on Sep 05 ’25, was worth 22,203. In this transaction Business Development Director of this company sold 30,000 shares at a rate of $0.74, taking the stock ownership to the 231,238 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Officer proposed sale 30,000 for $0.81, making the entire transaction worth $24,210.
NeuroOne Medical Technologies Corp (NMTC) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 75.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.32% during the next five years compared to 23.14% growth over the previous five years of trading.
NeuroOne Medical Technologies Corp (NASDAQ: NMTC) Trading Performance Indicators
Check out the current performance indicators for NeuroOne Medical Technologies Corp (NMTC). In the past quarter, the stock posted a quick ratio of 5.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.16, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.15 in one year’s time.
Technical Analysis of NeuroOne Medical Technologies Corp (NMTC)
The latest stats from [NeuroOne Medical Technologies Corp, NMTC] show that its last 5-days average volume of 0.7 million was superior to 0.3 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 53.34%.
During the past 100 days, NeuroOne Medical Technologies Corp’s (NMTC) raw stochastic average was set at 83.61%, which indicates a significant increase from 66.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0726 in the past 14 days, which was higher than the 0.0616 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8399, while its 200-day Moving Average is $0.8283. Now, the first resistance to watch is $1.1400. This is followed by the second major resistance level at $1.2200. The third major resistance level sits at $1.2800. If the price goes on to break the first support level at $1.0000, it is likely to go to the next support level at $0.9400. Assuming the price breaks the second support level, the third support level stands at $0.8600.
NeuroOne Medical Technologies Corp (NASDAQ: NMTC) Key Stats
There are currently 50,000K shares outstanding in the company with a market cap of 53.00 million. Presently, the company’s annual sales total 3,450 K according to its annual income of -12,320 K. Last quarter, the company’s sales amounted to 1,700 K and its income totaled -1,500 K.
